期刊文献+

小鼠调节性T细胞的CD4^+ CD25^+ CD127^(low/-)标记分析 被引量:11

Analysis of CD4^+ CD25^+ CD127^(low/-) Treg Cells in Mice
下载PDF
导出
摘要 新的特异性细胞表面标记的发现是提高调节性T细胞(Treg)测量和分选技术的重要环节,Foxp3是公认的天然Treg的标记,却不能作为分选细胞的标记,CD127是新发现低表达于Treg细胞表面的标记。本实验测定CD4+CD25+CD127low/-和CD4+CD25+Foxp3+标记的小鼠外周血及脾脏Treg细胞的数量,并测定CD4+CD25+CD127low/-细胞内Foxp3转录因子的表达水平,分析CD4+CD25+CD127low/-标记在小鼠Treg细胞测定及分选的价值。收集BALB/c小鼠外周血及制备脾细胞悬液,分别三重荧光染色CD4、CD25、CD127及CD4、CD25、Foxp3后应用流式细胞仪检测,得出CD4+CD25+CD127low/-、CD4+CD25+Foxp3+这两种标记的小鼠外周血和脾脏Treg细胞的比例;再在CD4、CD25、Foxp3基础上加CD127染色(四重荧光染色),检测CD4+CD25+CD127low/-细胞Foxp3转录因子的表达情况。结果显示:①BALB/c小鼠外周血CD4+T细胞的分布:在总T细胞中CD4+TCD4+CD25+T细胞的中位表达水平分别为39.02%、5.35%;在CD4+T细胞中CD4+CD25+CD127low/-、CD4+CD25+Foxp3+细胞的中位表达水平分别为7.13%、3.97%;②BALB/c小鼠脾脏CD4+T细胞的分布:在总T细胞中CD4+T、CD4+CD25+T细胞的中位表达水平分别为23.49%、3.86%;在CD4+T细胞中CD4+CD25+CD127low/-、CD4+CD25+Foxp3+细胞的中位表达水平分别为12.8%、8.23%;③BALB/c小鼠外周血和脾脏CD4+CD25+CD127low/-细胞比例高于CD4+CD25+Foxp3+细胞,以脾脏更为明显(P<0.01);④小鼠外周血及脾脏CD4+CD25+CD127low/-细胞高表达Foxp3转录因子,CD4+CD25+Foxp3+细胞低表达CD127。结论:BALB/c小鼠外周血和脾脏CD4+CD25+CD127low/-较CD4+CD25+Foxp3+能定量更多的Treg细胞;CD127low/-作为CD4+CD25+Treg细胞表面的特征性标志,在细胞分选时受其他细胞的干扰最小,是定量和纯化小鼠Treg细胞的更好标记选择。 The quantitative identification and enrichment of viable regulatory T cells (Treg) requires reliable surface markers that are selectively expressed on Treg. Foxp3 is the accepted marker of natural Treg, but it cannot be used to isolate cells for functional studies. CD127 is a new surface marker expressed in Treg cells. In this study, two populations of Treg, including CD4 ^+ CD25^+ CD127low/- and CD4^+ CD25^+ Foxp3^+ T cells, and profiles of the Foxp3 expression in CD4^+ CD25 ^+ CD127low/-cells were compared to evaluate which population is better. The peripheral blood cells were collected and spleen suspension of BALB/C mice were prepared, and using triple staining CD4, CD25, CD127 and CD4, CD25, Foxp3. The profiles of Treg, including CD4 ^+ CD25 ^+ CD127^+^+w/- and CD4 ^+ CD25 ^+ Foxp3 ^+ were detected by flow cytometry. The quadruple staining CD4, CD25, Foxp3 and CD127 were used to determine the CD127 expression in CD4 ^+ CD25^+ Foxp3^+ cells. The results showed that on T cell subset the median expression levels of CD4^+ , CD4^+ CD25 ^+ were 39.02% ,5.35% in peripheral blood and 23.49% ,3.86% in spleen. On CD4 ^+ T cell subset, the median expression level of CD4 ^+ CD25 ^+ CD127low/- and CD4 ^+ CD25 ^+ Foxp3 ^+ T cells were 7.13% ,3.97% in peripheral blood and 12.8% ,8.23% in spleen. The ratio of CD4 ^+ CD25 ^+ CD127low/- T cells was higher than that of CD4 ^+ CD25^+ Foxp3 ^+ cells in both peripheral blood and spleen cells ( P 〈 0.01 ). The CD4 ^+ CD25 ^+ CD127low/- cells highly expressed Foxp3, while the CD4 ^+ CD25 ^+ Foxp3 ^+ T cells lowly expressed CD127. It is concluded that compared with the CD4 ^+ CD25 ^+ Foxp3 ^+ populations, CD4 ^+ CD25 ^+ CD127low/- T cells better fit thedefinition of naturally occurring regulatory T ceils in peripheral blood cells and spleen of BALB/C mice. CD127low/- is a charicteristic marker on surface of CD4 ^+ CD25 ^+ Treg cells, and has been confirmed to be more specific marker for quantitatively sorting Treg cells.
出处 《中国实验血液学杂志》 CAS CSCD 北大核心 2012年第6期1469-1473,共5页 Journal of Experimental Hematology
基金 广东省科技计划项目资金资助(编号2009B030801019)
关键词 调节性T细胞 CD127 FOXP3 regulatory T cells CD127 Foxp3
  • 相关文献

参考文献13

  • 1Morgan ME, van Bilsen JH, Bakker AM, et al. Expression ofFOXP3 mRNA is notconfined to CD4 + CD25+ T regulatory cells in humans. Hum Immunol, 2005 ; 66 ( 1 ) : 13 - 20.
  • 2Allan SE, Passerini L, Bacchetta R, et al. The role of 2 FOXP3 iso- forms in the generation of human CD4 Tregs. J Clin Invest, 2005; 115( 11 ) : 3276 -3284.
  • 3Seddiki N, Santner-Nanan B, Martinson J, et al. Expression of in- terleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med, 2006 ; 203 (7) : 1693 - 1700.
  • 4Hartigan-O'Connor DJ, Poon C, Sinclair E, et al. Human CD4+ regulatory T cells express lower levels of the IL-7 receptor alphachain ( CD127), allowing consistent identification and sorting of live eells. Journal of Immunological Methods, 2007 ; 319 ( 1 - 2) : 41 - 52.
  • 5Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic self-toler- anee maintained by activated T cells expressing IL-2 receptor alpha- chains (CD25). Breakdown of a single mechanism of seff-toleranee causes various autoimmune diseases. J Immunol, 1995 ; 155 ( 3 ) : 1151 -1164.
  • 6Yagi H, Nomura T, Nakamura K, et al. Crucial role of FOXP3 in the development and function of human CD25 + CD4 + regulatory T cells. Int I mmunol, 2004 ; 16 ( 11 ) : 1643 - 1656.
  • 7Annunziato F, Cosmi L, Liotta F, et al. Phenotype, localization, and mechanism of suppression of CD4 + CD25 + human thymoeytes. J Exp Med, 2002; 196(3) : 379 -387.
  • 8刘凯山,孙万邦.CD4^+ CD25^+调节性T细胞及其临床应用[J].实用医学杂志,2010,26(11):2049-2051. 被引量:5
  • 9Cozzo C, Larkin J 3rd, Caton AJ. Cutting edge: self-peptides drive the peripheral expansion of CD4+ CD25+regulatory T cells. J Im- munol, 2003; 171(11): 5678-5682.
  • 10YuN, LiX, SongW, Li D,et al. CD4(+) CD25(+) CD127 (low/- ) T Cells: A More Specific Treg Population in Human Pe- ripheral Blood. Inflammation, 2012; July 1 [ Epub ahead of print].

二级参考文献44

  • 1杨江华,张永祥,苏川,孙南雄.慢性丙型肝炎患者CD4^+CD25^+调节性T细胞表达增加[J].世界华人消化杂志,2005,13(18):2201-2204. 被引量:10
  • 2韩梅,王冠军.CD4^+CD25^+免疫调节性T细胞对CD4^+T细胞介导的移植物抗宿主病预防作用的研究[J].中国免疫学杂志,2006,22(4):323-326. 被引量:6
  • 3李萍,毕黎琦,栗占国.表达Foxp3的调节性T细胞在类风湿关节炎发病中的意义[J].中国免疫学杂志,2006,22(4):368-370. 被引量:23
  • 4Sakaguchi S, Sakaguchi N, Asano M, et ah Immunologic self-tolerance maintained by activaled T cells expressing IL2 receptor alphachains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoinlmune diseases [J]. J Immunol, 1995,155 (3) : 1151-1164.
  • 5Pacholczyk R, Kraj P, Lgnatowiez L. Peptide specificity of thymic selectin of CD4^+CD25^+ cells [J]. J Immunol, 2002,168 (2) :613-620.
  • 6Fontenot J D, Gavin M A, Rudensky A Y, et al. Poxp3 programs the development and function of CD4^+CD25^+ regulatory T cells [J]. Nat Immuol, 2003,4(4) :330-336.
  • 7Feuerer M, Hill J A, Mathis D, et al. Foxp3+ regulatory T cells: differentiation, specification, sub phenotypes [J]. Nat Immunol, 2009,10(7):689- 695.
  • 8Seddiki N, Santner-Nanan B, Martinson J, et al. Expression of interleukin(IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells [J]. Exp Med,2006,203(7):1693-1700.
  • 9Hartigan-O'Connor D J, Poon C, Sinclair E, et al. Human CD4 (+) regulatory T cells express lower levels of the IL-7 receptor alpha chain (CD127), allowing consistent identification and sorting of live cells[J].Immunol Methods, 2007,319 (1-2) : 41-52.
  • 10Liu H, Leung B P. CD4^+CD25^+ regulatory T cells in health and disease [J]. Clin Exp Pharmacol Physiol, 2006,33(5-6) :519-524.

共引文献37

同被引文献86

  • 1刘莉,张军,方超平,杨佳荟,李闻捷,沈茜.流式细胞术检测人和小鼠Th细胞亚群[J].第三军医大学学报,2004,26(20):1845-1848. 被引量:17
  • 2张永梅,梁红,杨玉梅,徐继辉,徐军.丹皮酚对小鼠免疫功能的影响[J].包头医学院学报,2003,19(4):261-263. 被引量:14
  • 3黄莉莉,邵启祥,张慧,许逊,宗杨勇,陈述,申卫红,田小雷,彭鑫,王胜军,许化溪.PTD-Foxp3融合蛋白的表达、纯化及其生物学功能初步研究[J].江苏大学学报(医学版),2007,17(3):188-192. 被引量:6
  • 4Wang J J, Li QW, Ou YT, et al. Antitumor Effects of Paeonol on Mice Bearing EMT6 Breast Infiltrating Ductal Carcinoma [J]. Lat Am J Pharm,2010,9(3) :369-375.
  • 5Sun GP, Wang H, Xu SP, et al. Anti-tumor effects of Paeonol in a HepA-hepatoma bearing mouse model via induction of tumor cell apoptosis and stimulation of IL-2 and TNF-c production [J]. Eur J Pharm, 2008,584 : 246-252.
  • 6Wang J J, Li QW, Ou YT,et al. Immunoregulation effect of recombi- nant adenoviral mediated human lactoferrin gene on mice bearing EMT6 breast cancer[J].J Pharm Res,2010,3(9):2131-2133.
  • 7Abbas AK, Andrew H. Cellular and Molecular Immunology[M].5版.北京:北京大学医学出版社.2005:401-410.
  • 8Hung K, Hayashi R, Lafond-Walker A, et al. The Central Role of CD4+ T Ceils in the Antitumor Immune Response [J]. J Exp Med, 1998,188(12) :2357-2368.
  • 9Yu N, Li X, Song W, et al. CD4 (+)CD25 (+)CD127 (low/-)T cells :A more specific treg population in human pe-ripheral blood[J]. Inflammation, 2012,35 (6) : 1773-1780.
  • 10Tamada K, Chen L. Renewed interest in cancer immunotherapy with the tumor necrosis factor superfamily molecules [J]. Cancer Immunol Immunother, 2006,55 : 355-362.

引证文献11

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部